Efficacy of tofacitinib for the treatment of psoriatic arthritis: pooled analysis of two phase 3 studies
<strong>Introduction</strong> Tofacitinib is an oral Janus kinase inhibitor for the treatment of psoriatic arthritis (PsA). This post hoc analysis assessed the efficacy of tofacitinib using pooled data from two phase 3 studies of patients with active PsA. <br/><br/> <stron...
| Autori principali: | , , , , , , , , , , |
|---|---|
| Natura: | Journal article |
| Lingua: | English |
| Pubblicazione: |
Springer Nature
2018
|